Synthetic cannabinoid receptor agonists are monoamine oxidase‐A selective inhibitors
Abstract Synthetic cannabinoid receptor agonists (SCRAs) are one of the fastest growing classes of recreational drugs. Despite their growth in…
Ian S. Blagbrough
Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act
Abstract Background and aims: The United Kingdom (UK) Psychoactive Substances Act (PSA), implemented on the 26th May 2016, made the…
Synthetic Cannabinoid Receptor Agonists Detection Using Fluorescence Spectral Fingerprinting
Abstract Synthetic cannabinoid receptor agonists (SCRAs), termed “Spice” or “K2”, are molecules that emulate the effects of the active ingredient…